Literature DB >> 17075025

Are stem cells drugs? The regulation of stem cell research and development.

Michael R Rosen1.   

Abstract

Stem cell research and its clinical application have become political, social, and medical lightning rods, polarizing opinion among members of the lay community and among medical/scientific professionals. A potpourri of opinion, near-anecdotal observation, and scientifically sound data has sown confusion in ways rarely seen in the medical arts and sciences. A major issue is regulation, with different aspects of stem cell research falling within the purview of different government agencies and local offices. An overarching clearinghouse to review the field and recommend policy is lacking. In the following pages, I touch on the societal framework for regulation, the known and potential risks and benefits of cardiovascular stem cell therapies, whether stem cells should be regulated as drugs or in analogy to drugs, and if there is to be regulation, then by whom. In so doing, I refer to the stem cell literature only as it relates to the discussion of regulation because this is not a review of stem cell research; it is an opinion regarding regulation.

Mesh:

Year:  2006        PMID: 17075025     DOI: 10.1161/CIRCULATIONAHA.106.641670

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

Review 2.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

3.  Biological pacemaking: a concept whose time has come...or is coming.

Authors:  Michael R Rosen
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

Review 4.  Regenerative therapies in electrophysiology and pacing.

Authors:  Michael R Rosen; Peter R Brink; Ira S Cohen; Peter Danilo; Richard B Robinson; Amy B Rosen; Matthias J Szabolcs
Journal:  J Interv Card Electrophysiol       Date:  2008-03-25       Impact factor: 1.900

Review 5.  Cell therapy for left ventricular remodeling.

Authors:  Doris A Taylor; Andrey G Zenovich
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 6.  Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement.

Authors:  Michael R Rosen; Robert J Myerburg; Darrel P Francis; Graham D Cole; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2014-09-02       Impact factor: 24.094

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.